| Financial Year |
March 31 2023 |
| Monetary Funds |
1,482,199,839.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
38,377,491.43 |
| Accounts Receivable |
1,595,477,934.29 |
| Advances to Suppliers |
22,055,215.20 |
| Other Receivables |
197,348,968.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
433,359,390.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
151,826,055.28 |
| Total Current Assets |
4,317,911,549.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
118,019,333.40 |
| Long-term Equity Investment |
333,044,509.19 |
| Investment Properties |
124,288,560.41 |
| Fixed Assetes |
5,113,471,563.86 |
| Under-construction Projects |
450,949,536.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
745,721,843.68 |
| R&D expenses |
105,578,975.31 |
| Goodwill |
3,324,174.59 |
| Long-Term Deferred and Prepaid Expenses |
30,779,932.94 |
| Deferred Income Tax Assets |
136,673,704.36 |
| Other Non-Current Assets |
573,143,409.52 |
| Sub-Total of Non-Current Assets |
7,939,892,678.36 |
| Total Assets |
12,257,804,228.02 |
| Short-Term Loans |
577,392,353.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
264,491,321.89 |
| Accounts Payable |
1,224,614,659.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
50,197,762.54 |
| Taxes Payable |
28,382,599.72 |
| Interest Payable |
-- |
| Dividend Payable |
50,846,725.68 |
| Other payables |
580,101,457.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,349,818,276.24 |
| Other Current Liabilities |
226,163,540.96 |
| Sub-Total of Current Liabilities |
4,306,210,212.99 |
| Long-term Loans |
3,523,284,881.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
724,039,299.32 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
35,254,376.23 |
| Other Non-Current Liabilities |
724,000,000.00 |
| Sub-Total of Non-Current Liabilities |
5,183,400,454.75 |
| Total Liabilities |
9,489,610,667.74 |
| Paid-In Capital(Or Share Stock) |
769,168,670.00 |
| Capital Surplus |
1,710,203,263.27 |
| Surplus Reserve |
65,297,123.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-847,437,842.14 |
| Minority Stockholder's Interest |
1,083,699,185.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,684,494,374.69 |
| Owner's Equity（Stockholder's Equity） |
2,768,193,560.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,257,804,228.02 |
